Literature DB >> 17433875

Toll-like receptors and innate immunity in B-cell activation and antibody responses.

Antonio Lanzavecchia1, Federica Sallusto.   

Abstract

It has been known for almost 30 years that mouse B cells proliferate and differentiate to antibody-secreting cells when stimulated by microbial products such as lipopolysaccharide or CpG-containing DNA, but the relevance of these polyclonal responses remained elusive until recently. A breakthrough in the field has been the discovery of endosomal Toll-like receptors in B cells and their role in the production of autoantibodies. Since then, several reports have extended the role of Toll-like receptors in B-cell responses to thymus-independent and thymus-dependent antigens, and in antibody class switch in lymphoid and extralymphoid tissues. Considering the complexity of the system it is perhaps not surprising that the literature contains some contradictory findings. However, the scientific fecundity in this rapidly evolving field will probably give rise to discoveries that could be translated into more effective vaccines and immunotherapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17433875     DOI: 10.1016/j.coi.2007.04.002

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  59 in total

Review 1.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 2.  Role of adjuvants in modeling the immune response.

Authors:  Darrick Carter; Steven G Reed
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

Review 3.  TLR8: an innate immune receptor in brain, neurons and axons.

Authors:  Yinghua Ma; Robin L Haynes; Richard L Sidman; Timothy Vartanian
Journal:  Cell Cycle       Date:  2007-09-04       Impact factor: 4.534

4.  Immunostimulatory activity of haptenated proteins.

Authors:  Noah W Palm; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

5.  T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies.

Authors:  Constanze Hess; André Winkler; Alexandra K Lorenz; Vivien Holecska; Véronique Blanchard; Susanne Eiglmeier; Anna-Lena Schoen; Josephine Bitterling; Alexander D Stoehr; Dominique Petzold; Tim Schommartz; Maria M M Mertes; Carolin T Schoen; Ben Tiburzy; Anne Herrmann; Jörg Köhl; Rudolf A Manz; Michael P Madaio; Markus Berger; Hedda Wardemann; Marc Ehlers
Journal:  J Clin Invest       Date:  2013-08-27       Impact factor: 14.808

6.  Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.

Authors:  Maria Gounari; Stavroula Ntoufa; Benedetta Apollonio; Nikos Papakonstantinou; Maurilio Ponzoni; Charles C Chu; Davide Rossi; Gianluca Gaidano; Nicholas Chiorazzi; Kostas Stamatopoulos; Paolo Ghia
Journal:  Blood       Date:  2015-04-21       Impact factor: 22.113

7.  New insights into the functions of B cells.

Authors:  Samuel J Balin; Jeffrey L Platt; Marilia Cascalho
Journal:  Pediatr Transplant       Date:  2008-06-28

8.  TLRs innate immunereceptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1α-driven human polyclonal B-cell activation.

Authors:  Olivia Simone; Maria Teresa Bejarano; Susan K Pierce; Salvatore Antonaci; Mats Wahlgren; Marita Troye-Blomberg; Daria Donati
Journal:  Acta Trop       Date:  2011-05-19       Impact factor: 3.112

9.  2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.

Authors:  Colin M North; Robert B Crawford; Haitian Lu; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2010-03-26       Impact factor: 4.849

Review 10.  How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases?

Authors:  C Beck; H Morbach; P Richl; M Stenzel; H J Girschick
Journal:  Rheumatol Int       Date:  2008-09-28       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.